Ocata Therapeutics Inc fka OCAT

[rocky301]

louisa,


possible first injection in June as stated prior.

Roslin..no idea

Orphan desig in EU? psssible in June according to TMC Pharma's e-mail
http://investorstemcell.com/forum/advanced-cell-technology/2490.htm

EU CTA(clinical trial application for Stargardt) possible by end of June according to ACT PR dated April 20

"During the CTA review process, which requires a minimum of 60 days, the reviewers decide if an applicant is permitted to proceed with its proposed clinical trial."
http://www.advancedcell.com/news-and-media/press-releases/act-files-european-clinical-trial-application-for-phase-12-study-using-embryonic-stem-cells-to-treat-/

Korea? ACT hasn't mentioned it. Remember CHA acquired exclusive rights to RPE technology for Korea. CHA has access to almost everything ACT has done with FDA here and ACT per contract is to help them through the Korean process. This is not a JV as SCRMI is.